Patents by Inventor Sylvie Barchechath

Sylvie Barchechath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apoptosis inhibitors
    Patent number: 7816352
    Abstract: The present invention provides compounds that act as selective agents to protect against unintentional cell death or tissue damage and can relieve side effects of cancer treatment such as, for example, oral mucositis, hair loss, diarrhea due to damage to the gastrointestinal epithelium, and myelosuppression. In addition, these compounds can be used to prevent premature cell death when the cell death is caused by signals from damaged cells, for example, signals generated as the result of a traumatic incident or an ischemic episode.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: October 19, 2010
    Assignee: The Regents of The University of California
    Inventors: Dennis A. Carson, Howard B. Cottam, Sylvie Barchéchath, Mary Patricia Corr
  • Compounds having activity as inhibitors of apoptosis
    Patent number: 7601846
    Abstract: The present invention provides compounds that can protect mammalian cells from the damaging effects of chemotherapy, irradiation, or in other situations in which it is desirable to protect tissue from the consequences of clinical or environmental stress.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: October 13, 2009
    Assignee: The Regents of the University of California
    Inventors: Howard B. Cottam, Dennis A. Carson, Sylvie Barchechath
  • Apoptosis Inhibitors
    Publication number: 20080280903
    Abstract: The present invention provides compounds that act as selective agents to protect against unintentional cell death or tissue damage and can relieve side effects of cancer treatment such as, for example, oral mucositis, hair loss, diarrhea due to damage to the gastrointestinal epithelium, and myelosuppression. In addition, these compounds can be used to prevent premature cell death when the cell death is caused by signals from damaged cells, for example, signals generated as the result of a traumatic incident or an ischemic episode.
    Type: Application
    Filed: March 10, 2006
    Publication date: November 13, 2008
    Inventors: Dennis A. Carson, Howard B. Cottam, Sylvie Barchechath, Mary Patricia Corr
  • Compounds having activity as inhibitors of apoptosis
    Publication number: 20060122178
    Abstract: The present invention provides compounds that can protect mammalian cells from the damaging effects of chemotherapy, irradiation, or in other situations in which it is desirable to protect tissue from the consequences of clinical or environmental stress.
    Type: Application
    Filed: November 10, 2005
    Publication date: June 8, 2006
    Inventors: Howard Cottam, Dennis Carson, Sylvie Barchechath
  • Use of STAT-6 inhibitors as therapeutic agents
    Publication number: 20030143199
    Abstract: The present invention provides A therapeutic method to enhance the efficacy of interferon treatment comprising administering to a mammal subject to interferon treatment a compound which is an antagonist of the IL-4 or IL-13 signal transduction pathway in an amount effective to enhance said efficacy. The method includes treatment of diseases such as cancer, proliferative fibrotic diseases, viral diseases, or autoimmune diseases. The invention also includes the use of chemotherapeutic agents, radiation or other treatments in conjunction with the method of the invention.
    Type: Application
    Filed: October 9, 2002
    Publication date: July 31, 2003
    Inventors: Dennis A. Carson, Howard B. Cottam, Lorenzo M. Leoni, Sylvie Barchechath